Farther Finance Advisors’s Opus Genetics IRD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRD
Farther Finance Advisors's IRD Position: Q2 2026 in Review
Farther Finance Advisors increased its Opus Genetics (IRD) stake by 52% in Q2 2026, buying an estimated $5.55K and bringing the position to 3,490 shares worth $14.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4201.
Farther Finance Advisors first reported a position in IRD in Q1 2026 and has held it in 2 quarters since. 2 funds tracked by Wall St. Rank hold IRD as of Q2 2026.
- Farther Finance Advisors held 3,490 shares of Opus Genetics worth $14.3K as of Q2 2026.
- Farther Finance Advisors bought 1,190 Opus Genetics shares in Q2 2026, an estimated $5.55K.
- Opus Genetics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4201 holding.
- Farther Finance Advisors first reported a position in Opus Genetics in Q1 2026 and has held it in 2 quarters since.
- 2 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2026.
Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.